Table 2.
Subgroup | No. of studies | Summary OR | 95 % CI | Heterogeneity | ||
---|---|---|---|---|---|---|
Q | P | I 2 (%) | ||||
Hip fracture | ||||||
Geographic area | ||||||
Asia | 2 | 1.790 | 1.729–1.854 | 0.63 | 0.428 | 0.0 |
Europe | 5 | 1.308 | 1.084–1.579 | 1.68 | 0.794 | 0.0 |
North America | 5 | 1.197 | 0.973–1.473 | 14.49 | 0.006 | 72.4 |
Study design | ||||||
Cohort | 10 | 1.304 | 1.072–1.586 | 74.7 | 0.000 | 87.9 |
Cross-sectional | 2 | 1.007 | 0.330–3.075 | 0.35 | 0.556 | 0.0 |
Vertebral fracture | ||||||
Geographic area | ||||||
Asia | 2 | 1.140 | 0.753–1.727 | 1.73 | 0.189 | 42.1 |
Europe | 3 | 1.139 | 0.439–2.958 | 2.92 | 0.233 | 31.4 |
North America | 2 | 1.084 | 0.765–1.536 | 2.31 | 0.128 | 56.7 |
Study design | ||||||
Cohort | 3 | 1.058 | 0.818–1.369 | 3.19 | 0.202 | 37.4 |
Cross-sectional | 4 | 1.315 | 0.889–1.944 | 3.11 | 0.376 | 3.4 |
P—P for heterogeneity